JOHN MENDLEIN

Profile

First Name

: JOHN

Middle Name

:

Last Name

: MENDLEIN

Related Companies
Titles
Company Name
Related People
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-06-24 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-04-07 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-10 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2016-11-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-08-10 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2016-08-09 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-02-10 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2015-05-07 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2015-01-30 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-19 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-11-06 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2013-11-06 
D
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Debt 
2013-08-08 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-05-04 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-11-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-03-30 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2010-12-02 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2010-03-15 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-11-10 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-11-10 
D
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2009-09-09